Bioavailability and reversible metabolism of prednisone and prednisolone in man

The pharmacokinetics of prednisone and prednisolone was examined in 12 healthy male subjects to assess the bioavailability and the parameters of reversible metabolism between the two steroids. After an oral prednisone dose of 0.8 mg kg−1 and an intravenous prednisolone dose of 0.66 mg kg−1, the bioavailability was found to be about 62%. The fraction of the dose recovered in the urine as the hydroxylated metabolites of prednisone and prednisolone was lower after the oral prednisone dose, suggesting that poor absorption of prednisone was the main cause of the low bioavailability. There was a high degree of interconversion between prednisone and prednisolone with 76% of the dose being recycled. The formation clearance of prednisolone from prednisone is much greater than the formation clearance of prednisone from prednisolone or the irreversible elimination clearances of the two steroids. The possible dose dependences of bioavailability and interconversion may be important factors in prednisolone therapy.

[1]  J. Melby,et al.  Comparative studies on absorption and metabolic disposal of water-soluble corticosteroid esters. , 1961, Metabolism: clinical and experimental.

[2]  W. Jusko,et al.  Corticosteroid analysis in biological fluids by high-performance liquid chromatography. , 1979, Journal of chromatography.

[3]  W J Jusko,et al.  LAGRAN program for area and moments in pharmacokinetic analysis. , 1983, Computer programs in biomedicine.

[4]  F. Frey,et al.  The dose-dependent systemic availability of prednisone: one reason for the reduced biological effect of alternate-day prednisone. , 1986, British journal of clinical pharmacology.

[5]  A. Atkinson,et al.  Comparison of prednisolone kinetics in patients receiving daily or alternate‐day prednisone for asthma , 1986, Clinical pharmacology and therapeutics.

[6]  F. Frey Kinetics and dynamics of prednisolone. , 1987, Endocrine reviews.

[7]  F. Frey,et al.  Kinetics of prednisolone and endogenous cortisol suppression in the elderly , 1988 .

[8]  J. Ferry,et al.  Relative and Absolute Bioavailability of Prednisone and Prednisolone After Separate Oral and Intravenous Doses , 1988, Journal of clinical pharmacology.

[9]  F. Horber,et al.  Altered metabolism and decreased efficacy of prednisolone and prednisone in patients with hyperthyroidism , 1988, Clinical pharmacology and therapeutics.

[10]  F. Frey,et al.  Impact of ketoconazole on the metabolism of prednisolone , 1989, Clinical pharmacology and therapeutics.

[11]  W. Jusko,et al.  Pharmacokinetics of Linear Reversible Metabolic Systems , 1991 .

[12]  W. Jusko,et al.  Simultaneous analysis of prednisone, prednisolone and their major hydroxylated metabolites in urine by high-performance liquid chromatography. , 1991, Journal of chromatography.